Philip C. Hogan

459 total citations
15 papers, 356 citations indexed

About

Philip C. Hogan is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Philip C. Hogan has authored 15 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Inorganic Chemistry. Recurrent topics in Philip C. Hogan's work include Chemical Synthesis and Analysis (5 papers), Asymmetric Hydrogenation and Catalysis (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Philip C. Hogan is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Asymmetric Hydrogenation and Catalysis (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Philip C. Hogan collaborates with scholars based in United States. Philip C. Hogan's co-authors include Andrew G. Myers, E. J. Corey, Alexander R. Hurd, Alan J. Anderson, Chi-Li Chen, Steven D. Goldberg, Magnus Rönn, Zhijian Zhu, Diana K. Hunt and Xiao-Yi Xiao and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Philip C. Hogan

15 papers receiving 328 citations

Peers

Philip C. Hogan

OC

MB

PHARM

MM

BIOTE

Jingye Zhou United States

Eiki Shitara Japan

Monica H. Palme United States

YASUTAKA SHIMAUCHI United Kingdom

Anthony Stapon United States

Gerardo O. Danelón Argentina

Danièle Sevère France

Shinpei Hirano Japan

Samar S. Fatahala Egypt

Yukitoshi Narukawa Japan

Jingye Zhou United States

Philip C. Hogan

208 ×0.9

OC

81 ×0.6

MB

81 ×0.7

PHARM

58 ×1.0

MM

33 ×1.2

BIOTE

Citations per year, relative to Philip C. Hogan Philip C. Hogan (= 1×) peers Jingye Zhou

Countries citing papers authored by Philip C. Hogan

Since Specialization

Citations

This map shows the geographic impact of Philip C. Hogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip C. Hogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip C. Hogan more than expected).

Fields of papers citing papers by Philip C. Hogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip C. Hogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip C. Hogan. The network helps show where Philip C. Hogan may publish in the future.

Co-authorship network of co-authors of Philip C. Hogan

This figure shows the co-authorship network connecting the top 25 collaborators of Philip C. Hogan. A scholar is included among the top collaborators of Philip C. Hogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip C. Hogan. Philip C. Hogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Hogan, Philip C., et al.. (2017). Large-scale preparation of key building blocks for the manufacture of fully synthetic macrolide antibiotics. The Journal of Antibiotics. 71(2). 318–325. 17 indexed citations

2.

Zhang, Wu‐Yan, et al.. (2017). Process Research and Development of TP-808: A Key Intermediate for the Manufacture of Synthetic Tetracyclines. Organic Process Research & Development. 21(3). 377–386. 8 indexed citations

3.

Zhang, Wu‐Yan, Cuixiang Sun, Diana K. Hunt, et al.. (2015). Process Development and Scale-up of Fully Synthetic Tetracycline TP-2758: A Potent Antibacterial Agent with Excellent Oral Bioavailability. Organic Process Research & Development. 20(2). 284–296. 9 indexed citations

4.

Zhang, Wu‐Yan, Philip C. Hogan, Chi-Li Chen, et al.. (2015). Process Research and Development of an Enantiomerically Enriched Allyic Amine, One of the Key Intermediates for the Manufacture of Synthetic Tetracyclines. Organic Process Research & Development. 19(11). 1784–1795. 14 indexed citations

5.

Apelian, Diran, et al.. (2013). The continuous rheoconversion process (CRP™): optimization & industrial applications. 24(2). 1 indexed citations

6.

Clark, Roger B., Cuixiang Sun, Chi-Li Chen, et al.. (2013). Synthesis and Biological Evaluation of 8-Aminomethyltetracycline Derivatives as Novel Antibacterial Agents. Journal of Medicinal Chemistry. 56(20). 8112–8138. 12 indexed citations

7.

Rönn, Magnus, Zhijian Zhu, Philip C. Hogan, et al.. (2013). Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development. Organic Process Research & Development. 17(5). 838–845. 49 indexed citations

8.

Clark, Roger B., Diana K. Hunt, Chi-Li Chen, et al.. (2011). Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy. Journal of Medicinal Chemistry. 55(2). 606–622. 59 indexed citations

9.

Rönn, Magnus, et al.. (2011). An Expedient Route to 3-Methoxy-2-furaldehyde. Synlett. 2012(1). 134–136. 1 indexed citations

10.

Hogan, Philip C., et al.. (2007). Kedarcidin Chromophore: Synthesis of Its Proposed Structure and Evidence for a Stereochemical Revision. Journal of the American Chemical Society. 129(17). 5381–5383. 57 indexed citations

11.

Hogan, Philip C., et al.. (2007). Synthesis of l-Kedarosamine in Protected Form and Its Efficient Incorporation into an Advanced Intermediate to Kedarcidin Chromophore. Organic Letters. 9(10). 1923–1925. 11 indexed citations

12.

Hogan, Philip C. & E. J. Corey. (2005). Proteasome Inhibition by a Totally Synthetic β-Lactam Related to Salinosporamide A and Omuralide. Journal of the American Chemical Society. 127(44). 15386–15387. 51 indexed citations

13.

Myers, Andrew G., Philip C. Hogan, Alexander R. Hurd, & Steven D. Goldberg. (2002). Enantioselective Synthesis of Kedarcidin Chromophore Aglycon in Differentially Protected Form. Angewandte Chemie International Edition. 41(6). 1062–1067. 35 indexed citations

14.

Myers, Andrew G., Philip C. Hogan, Alexander R. Hurd, & Steven D. Goldberg. (2002). Enantioselective Synthesis of Kedarcidin Chromophore Aglycon in Differentially Protected Form. Angewandte Chemie. 114(6). 1104–1109. 11 indexed citations

15.

Myers, Andrew G., Alexander R. Hurd, & Philip C. Hogan. (2002). Evidence for Facile Atropisomerism and Simple (Non-Nucleophilic) Biradical-Forming Cycloaromatization within Kedarcidin Chromophore Aglycon. Journal of the American Chemical Society. 124(17). 4583–4585. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact